Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: A cross-sectional study in Japanese men and women

European Journal of Clinical Nutrition

Volumn 64, Issue 10, 2010, Pages 1179-1185

  Oya, J ^a   Nakagami, T ^a   Sasaki, S ^b   Jimba, S ^a   Murakami, K ^b   Kasahara, T ^c   Wasada, T ^d   Sekiguchi, H ^c   Hasegawa, M ^a   Endo, Y ^c   Iwamoto, Y ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Saiseikai Kurihashi Hospital   (Japan)

^d Totsuka Royal Clinic   (Japan)

Author keywords

epidemiology; Japanese; n 3 PUFAs; NAFLD

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; FAT INTAKE; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; NUTRITIONAL ASSESSMENT; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; ALPHA-LINOLENIC ACID; CROSS-SECTIONAL STUDIES; DIET; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FATTY LIVER; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PREVALENCE; QUESTIONNAIRES; SEX FACTORS;

EID: 77957854056     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2010.139     Document Type: Article

References (37)

1. Allard JP, Aghdassi E, Mohammed S, Raman M, Avand G, Arendt BM et al. (2008). Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. J Hepatol 48, 300-307.
2. Browning JD, Horton JD (2004). Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114, 147-152.
3. Capanni M, Calella F, Biagini MR, Genise S, Raimondi L, Bedogni G et al. (2006). Prolonged n-3 polyunsaturated fatty acid supple-mentation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther 23, 1143-1151.
4. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C et al. (1990). NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 12, 1106-1110.
5. Clark JM, Brancati FL, Diehl AM (2002). Nonalcoholic fatty liver disease. Gastroenterology 122, 1649-1657.
6. Debongnie JC, Pauls C, Fievez M, Wibin E (1981). Prospective evaluation of the diagnostic accuracy of liver ultrasonography. Gut 22, 130-135.
7. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005). Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115, 1343-1351.
8. Foster KJ, Dewbury KC, Griffith AH, Wright R (1980). The accuracy of ultrasound in the detection of fatty infiltration of the liver. Br J Radiol 53, 440-442.
9. Goessling W, Massaro JM, Vasan RS, D'Agostino Sr RB, Ellison RC, Fox CS (2008). Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 135, 1935-1944.
10. Gore RM (1994). Diffuse liver disease. In: Gore RM, Levine MS, Laufer I. Textbookof Gastrointestinal Radiology. Saunders: Philadelphia.
11. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T et al. (2007). The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 102, 2708-2715.
12. Itoh M, Suganami T, Satoh N, Tanimoto-Koyama K, Yuan X, Tanaka M et al. (2007). Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 27, 1918-1925.
13. Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M, Bennett C et al. (2007). Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 27, 412-421.
14. Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y et al. (2005). Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 22, 1141-1145.
15. Joseph AEA, Saverymuttu SH, Al-Sam S, Cook MG, Maxwell JD (1991). Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver diseases. Clin Radiol 43, 26-31.
16. Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW et al. (2004). Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 164, 2169-2175.
17. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S (2003). Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 38, 954-961.
18. Madsen T, Skou HA, Hansen VE, Fog L, Christensen JH, Toft E et al. (2001). C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol 88, 1139-1142.
19. Nishino M, Hayakawa K, Nakamura Y, Morimoto T, Mukaihara S (2003). Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy. AJR Am J Roentgenol 180, 129-134.
20. Perez-Matute P, Perez-Echarri N, Martinez JA, Marti A, Moreno-Aliaga MJ (2007). Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-alpha. Br J Nutr 97, 389-398.
21. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M et al. (2002). The utility of radiological imaging in non-alcoholic fatty liver disease. Gastroenterology 123, 745-750.
22. Sasaki S (2004). Development and evaluation of dietary assessment methods using biomarkers and diet history questionnaires for individuals. (head investigator: Tanaka H) Research for Evaluation Methods of Nutrition and Dietary Lifestyle Programs held on Healthy Japan 21. Summary Report of the Ministry of Health, Labour and Warfare. Ministry of Health, Labour and Warfare: Japan, pp 10-44 (inJapanese).
23. Sasaki S, Yanagibori R, Amano K (1998). Self-administered diet history questionnaire developed for health education: a relative validation of the test-version by comparison with 3-day diet record in women. J Epidemiol 8, 203-215.
24. Saverymuttu SH, Joseph AEA, Maxwell JD (1986). Ultrasound scanning in the detection of hepatic fibrosis and steatosis. BMJ 292, 13-15.
25. Schwarz JM, Neese RA, Turner S, Dare D, Hellerstein MK (1995). Short-term alterations in carbohydrate energy intake in humans. J Clin Invest 96, 2735-2743.
26. Sessler AM, Ntambi JM (1998). Polyunsaturated fatty acid regulation of gene expression. J Nutr 128, 923-926.
27. Solga S, Alkhuraishe AR, Clark JM, Torbenson M, Greenwald A, Diehl AM et al. (2004). Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci 49, 1578-1583.
28. Spadaro L, Magliocco O, Spampinato D, Piro S, Oliveri C, Alagona C et al. (2008). Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis 40, 194-199.
29. Sugano M, Hirahara F (2000). Polyunsaturated fatty acids in the food chain inJapan. Am J Clin Nutr 71 (Suppl), S189-S196.
30. Tanaka N, Sano K, Horiguchi A, Tanaka E, Kiyosawa K, Aoyama T (2008). Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol 42, 413-418.
31. Targher G (2007). Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 24, 1-6.
32. The Japan Society of Hepatology (2006). Guideline for treatment of NASH/NAFLD. In: Okaue T (ed). Bunkodo: Tokyo. pp 40-47 (inJapanese).
33. Vega GL, Chandalia M, Szczepaniak LS, Grundy SM (2008). Effects of n-3 fatty acids on hepatic triglyceride content in humans. J Investig Med 56, 780-785.
34. Weston SR, Leyden W, Murphy R, Bass NM, Bell BP, Manos MM et al. (2005). Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 41, 372-379.
35. Yamazaki T, Nakamori A, Sasaki E, Wada S, Ezaki O (2007). Fish oil prevents sucrose-induced fatty liver but exacerbates high-safflower oil-induced fatty liver in ddY mice. Hepatology 46, 1779-1790.
36. Yoshikawa T, Shimano H, Yahagi N, Ide T, Matsuzaka T, Nakakuki M et al. (2002). Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem 277, 1705-1711.
37. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, Halpern Z et al. (2007). Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study. J Hepatol 47, 711-717.